Activating mutations in fibroblast growth factor receptor 2 (FGFR2) cause several craniosynostosis syndromes by affecting the proliferation and differentiation of osteoblasts, which form the calvarial bones (8). The gene discussed is FGFR2; the disease is syndromic craniosynostosis.